Repository logo
 

Early nutrition, epigenetics, and cardiovascular disease.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Loche, Elena 
Ozanne, Susan E 

Abstract

PURPOSE OF REVIEW: Here, we provide a summary of the current knowledge on the impact of early life nutrition on cardiovascular diseases that have emerged from studies in humans and experimental animal models. The involvement of epigenetic mechanisms in the Developmental Origins of Health and Disease will be discussed in relation to the implications for the heart and the cardiovascular system. RECENT FINDINGS: Environmental cues, such as parental diet and a suboptimal in utero environment can shape growth and development, causing long-lasting cardiometabolic perturbations. Increasing evidence suggest that these effects are mediated at the epigenomic level, and can be passed onto future generations. In the last decade, epigenetic mechanisms (DNA methylation, histone modifications) and RNA-based mechanisms (microRNAs, piRNAs, and tRNAs) have therefore emerged as potential candidates for mediating inheritance of cardiometabolic diseases. SUMMARY: The burden of obesity and associated cardiometabolic diseases is believed to arise through interaction between an individual's genetics and the environment. Moreover, the risk of developing poor cardiometabolic health in adulthood is defined by early life exposure to pathological cues and can be inherited by future generations, initiating a vicious cycle of transmission of disease. Elucidating the molecular triggers of such a process will help tackle and prevent the uncontrolled rise in obesity and cardiometabolic disease.

Description

Keywords

Animals, Cardiovascular Diseases, Diet, Epigenesis, Genetic, Histones, Humans, Nutritional Status, RNA, Small Untranslated

Journal Title

Curr Opin Lipidol

Conference Name

Journal ISSN

0957-9672
1473-6535

Volume Title

Publisher

Ovid Technologies (Wolters Kluwer Health)
Sponsorship
Medical Research Council (MC_UU_12012/4)
British Heart Foundation (None)
British Heart Foundation (None)
Medical Research Council (MC_PC_12012)
Our research is supported by the Medical Research Council (MRC; MC_UU_12012/4) and the British Heart Foundation (FS/12/64/30001 and PG/14/20/30769).